九典制药
(300705)
| 流通市值：47.40亿 | | | 总市值：64.29亿 |
| 流通股本：3.69亿 | | | 总股本：5.00亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 499,736,235.89 | 453,699,715.46 | 543,737,630.21 | 538,890,797.85 |
| 交易性金融资产 | 120,048,835.62 | 161,286,632.06 | 130,727,978.93 | 130,797,836.14 |
| 衍生金融资产 | - | 0 | - | 0 |
| 应收票据及应收账款 | 356,495,753.42 | 377,703,133.8 | 359,022,775.86 | 403,199,351.62 |
| 其中：应收票据 | 60,431,486.86 | 71,195,405.63 | 38,193,008.75 | 39,441,967.48 |
| 应收账款 | 296,064,266.56 | 306,507,728.17 | 320,829,767.11 | 363,757,384.14 |
| 应收款项融资 | 112,101,673.35 | 128,888,897.87 | 76,247,880.23 | 70,542,918.93 |
| 预付款项 | 67,530,749.89 | 60,060,392.76 | 67,279,825.72 | 67,447,876.54 |
| 其他应收款合计 | 5,135,714.01 | 5,436,885.78 | 5,970,071.99 | 7,748,283.37 |
| 其中:应收利息 | - | 0 | - | 0 |
| 应收股利 | - | 0 | - | 0 |
| 存货 | 380,291,435.56 | 350,675,218.19 | 396,201,736.89 | 404,417,613.32 |
| 其他流动资产 | 3,663,124.25 | 1,539,498.66 | 0 | 9,959,281.76 |
| 流动资产合计 | 1,545,003,521.99 | 1,539,290,374.58 | 1,579,187,899.83 | 1,633,003,959.53 |
| 非流动资产: | | | | |
| 债权投资 | - | 0 | - | 0 |
| 其他债权投资 | - | 0 | - | 0 |
| 长期应收款 | - | 0 | - | 0 |
| 长期股权投资 | 151,499,896.97 | 94,549,406.62 | 95,836,414.65 | 83,567,813.77 |
| 其他权益工具投资 | 98,868,311.49 | 98,868,311.49 | 98,868,311.49 | 98,868,311.49 |
| 其他非流动金融资产 | - | 0 | - | 0 |
| 投资性房地产 | 0 | 4,285,680.2 | 4,365,765.57 | 4,445,850.95 |
| 固定资产 | 1,442,735,562.04 | 1,436,641,417.04 | 1,342,356,756.07 | 1,311,591,357.36 |
| 在建工程 | 165,266,814.37 | 135,373,585.92 | 117,171,654.58 | 93,712,940.53 |
| 生产性生物资产 | - | 0 | - | 0 |
| 油气资产 | - | 0 | - | 0 |
| 使用权资产 | 1,078,978.85 | 1,186,876.73 | 0 | 0 |
| 无形资产 | 571,113,469.53 | 561,256,414.51 | 128,843,464.03 | 113,466,637.59 |
| 开发支出 | 35,933,824.01 | 34,104,818.82 | 58,104,736.46 | 52,995,883.25 |
| 商誉 | 270,307.81 | 270,307.81 | 0 | 0 |
| 长期待摊费用 | 6,806,116.58 | 5,622,186.6 | 6,135,491.32 | 5,606,381.74 |
| 递延所得税资产 | 59,307,202.32 | 57,985,494.61 | 43,630,881.69 | 43,646,940.29 |
| 其他非流动资产 | 41,892,587.92 | 49,400,810.57 | 196,355,102.51 | 90,556,834.74 |
| 非流动资产合计 | 2,574,773,071.89 | 2,479,545,310.92 | 2,091,668,578.37 | 1,898,458,951.71 |
| 资产总计 | 4,119,776,593.88 | 4,018,835,685.5 | 3,670,856,478.2 | 3,531,462,911.24 |
| 流动负债: | | | | |
| 短期借款 | 20,014,819.45 | 12,007,791.66 | 0 | 0 |
| 应付票据及应付账款 | 117,660,653.06 | 91,149,245 | 111,277,775.87 | 142,431,984.85 |
| 其中：应付票据 | 0 | 0 | 879,470 | 509,470 |
| 应付账款 | 117,660,653.06 | 91,149,245 | 110,398,305.87 | 141,922,514.85 |
| 合同负债 | 61,815,391.39 | 46,694,315.66 | 27,597,949.08 | 28,022,155.85 |
| 应付职工薪酬 | 33,273,448.5 | 63,782,462.42 | 36,290,260.13 | 35,153,148.55 |
| 应交税费 | 40,177,449.33 | 58,592,975.57 | 37,667,573.81 | 26,703,656.44 |
| 其他应付款合计 | 66,809,430.61 | 73,596,567.11 | 57,023,822.35 | 58,262,714.85 |
| 其中:应付利息 | - | 0 | - | 0 |
| 应付股利 | - | 0 | - | 0 |
| 一年内到期的非流动负债 | 46,253,971.97 | 44,951,601.87 | 35,454,845.76 | 31,595,674.3 |
| 其他流动负债 | 28,085,206.56 | 31,669,963.79 | 23,324,278.43 | 19,325,292.55 |
| 流动负债合计 | 414,090,370.87 | 422,444,923.08 | 328,636,505.43 | 341,494,627.39 |
| 非流动负债: | | | | |
| 长期借款 | 327,410,380 | 295,663,680 | 280,648,380 | 240,965,080 |
| 应付债券 | 177,383,181.64 | 175,037,075.74 | 172,692,261.73 | 170,396,114.67 |
| 优先股 | - | 0 | - | 0 |
| 永续债 | - | 0 | - | 0 |
| 租赁负债 | 595,049.58 | 740,798.06 | 0 | 0 |
| 长期应付款 | 121,079,166.67 | 95,500,000 | 1,500,000 | 0 |
| 长期应付职工薪酬 | - | 0 | - | 0 |
| 预计负债 | - | 0 | - | 0 |
| 递延收益 | 228,221,854.38 | 233,322,754.4 | 179,287,254.56 | 184,117,624.05 |
| 递延所得税负债 | 9,738,465.87 | 9,898,702.67 | 13,131,844.5 | 4,563,409.34 |
| 其他非流动负债 | - | 0 | - | 0 |
| 非流动负债合计 | 864,428,098.14 | 810,163,010.87 | 647,259,740.79 | 600,042,228.06 |
| 负债合计 | 1,278,518,469.01 | 1,232,607,933.95 | 975,896,246.22 | 941,536,855.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 500,291,126 | 500,291,060 | 500,212,488 | 500,211,714 |
| 其他权益工具 | 39,485,789.8 | 39,486,025.75 | 39,486,570.41 | 48,438,329.11 |
| 资本公积 | 458,474,346.22 | 481,501,612.51 | 563,965,437.45 | 584,910,978.5 |
| 减:库存股 | 100,047,173.88 | 100,047,173.88 | 100,047,173.88 | 100,001,068.88 |
| 其他综合收益 | 4,882,664.77 | 4,882,664.77 | 4,882,664.77 | 4,882,664.77 |
| 专项储备 | 795,547.16 | 0 | 250,614.78 | 151,521.81 |
| 盈余公积 | 200,827,070.75 | 200,827,070.75 | 165,874,571.12 | 165,874,571.12 |
| 未分配利润 | 1,588,635,783.43 | 1,531,899,685.29 | 1,500,396,680.05 | 1,385,457,345.36 |
| 归属于母公司股东权益合计 | 2,693,345,154.25 | 2,658,840,945.19 | 2,675,021,852.7 | 2,589,926,055.79 |
| 少数股东权益 | 147,912,970.62 | 127,386,806.36 | 19,938,379.28 | 0 |
| 股东权益合计 | 2,841,258,124.87 | 2,786,227,751.55 | 2,694,960,231.98 | 2,589,926,055.79 |
| 负债和股东权益合计 | 4,119,776,593.88 | 4,018,835,685.5 | 3,670,856,478.2 | 3,531,462,911.24 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-30 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |